Table 2.
Age-adjusted cancer mortality rate (CMR) per 100,000 by racial/ethnic groups in New York City, 2001–2010.
| API | White | Hispanic | Black | |||||
|---|---|---|---|---|---|---|---|---|
| Cancer Type | CMR | (95%CI) | CMR | (95%CI) | CMR | (95%CI) | CMR | (95%CI) |
| Males | ||||||||
| All cancers | ||||||||
| Nasopharynxa | 2.57 | (2.06, 3.07) | 0.29 | (0.22, 0.39) | 0.31 | (0.20, 0.48) | 0.48 | (0.34, 0.66) |
| Esophagus | 3.4 | (2.7, 4.1) | 5.9 | (5.6, 6.3) | 5.8 | (5.1, 6.4) | 7.6 | (6.9, 8.3) |
| Liver | 15.9 | (14.6, 17.3) | 7.9 | (7.5, 8.3) | 13.6 | (12.7, 14.5) | 11.6 | (10.8, 12.4) |
| Stomach | 11.8 | (10.5, 13.0) | 6.0 | (5.6, 6.3) | 8.6 | (7.8, 9.4) | 10.2 | (9.4, 11.0) |
| Colon | 14.8 | (13.4, 16.3) | 20.8 | (20.1, 21.4) | 18.4 | (17.2, 19.6) | 26.4 | (25.1, 27.7) |
| Lung | 38.2 | (36.0, 40.5) | 49.5 | (48.4, 50.5) | 33.5 | (31.9, 35.1) | 54.3 | (52.5, 56.1) |
| Prostate | 8.0 | (6.9, 9.2) | 18.7 | (18.0, 19.3) | 24.1 | (22.6, 25.6) | 49.2 | (47.3, 51.1) |
|
| ||||||||
| Females | ||||||||
| All cancers | ||||||||
| Nasopharynxa | 0.67 | (0.55, 0.94) | 0.13 | (0.08, 0.19) | 0.13 | (0.07, 0.23) | 0.28 | (0.19, 0.39) |
| Esophagus | 0.8 | (0.6, 1.2) | 1.7 | (1.5, 1.8) | 1.2 | (1.0, 1.4) | 2.6 | (2.3, 2.9) |
| Liver | 5.4 | (4.7, 6.2) | 3.0 | (2.8, 3.3) | 4.9 | (4.5, 5.4) | 3.8 | (3.4, 4.1) |
| Stomach | 5.6 | (4.9, 6.4) | 3.5 | (3.2, 3.7) | 4.8 | (4.3, 5.2) | 5.5 | (5.1, 6.0) |
| Colon | 9.7 | (8.7, 10.7) | 14.4 | (13.9, 14.9) | 12.3 | (11.5, 13.0) | 18.0 | (17.2, 18.8) |
| Lung | 16.7 | (15.4, 18.0) | 32.5 | (31.8, 33.2) | 14.7 | (13.9, 15.4) | 29.0 | (28.0, 30.0) |
| Breast | 9.8 | (8.9, 10.8) | 25.3 | (24.7, 26.0) | 16.4 | (15.6, 17.2) | 29.7 | (28.7, 30.6) |
| Ovary | 4.6 | (3.9, 5.2) | 9.4 | (9.0, 9.8) | 5.1 | (4.7, 5.6) | 6.9 | (6.4, 7.4) |
| Cervix | 2.1 | (1.7, 2.6) | 1.9 | (1.7, 2.1) | 3.2 | (2.9, 3.6) | 5.1 | (4.7, 5.5) |
aAll nasopharyngeal cancer mortality rates reported to hundredth decimal place for accuracy.